BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 33957209)

  • 1. In silico network pharmacology and in vivo analysis of berberine-related mechanisms against type 2 diabetes mellitus and its complications.
    Di S; Han L; An X; Kong R; Gao Z; Yang Y; Wang X; Zhang P; Ding Q; Wu H; Wang H; Zhao L; Tong X
    J Ethnopharmacol; 2021 Aug; 276():114180. PubMed ID: 33957209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the synergistic and complementary effects of berberine and paeoniflorin in the treatment of type 2 diabetes mellitus by network pharmacology.
    Zhang L; Han L; Ma J; Wu T; Wei Y; Zhao L; Tong X
    Eur J Pharmacol; 2022 Mar; 919():174769. PubMed ID: 35151646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanism of Fufang Zhenzhu Tiaozhi capsule in the treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease based on network pharmacology and validation in minipigs.
    Wang H; Tan H; Zhan W; Song L; Zhang D; Chen X; Lin Z; Wang W; Yang Y; Wang L; Bei W; Guo J
    J Ethnopharmacol; 2021 Jun; 274():114056. PubMed ID: 33771638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Berberine alleviates type 2 diabetic symptoms by altering gut microbiota and reducing aromatic amino acids.
    Yao Y; Chen H; Yan L; Wang W; Wang D
    Biomed Pharmacother; 2020 Nov; 131():110669. PubMed ID: 32937246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression.
    Zhang H; Wei J; Xue R; Wu JD; Zhao W; Wang ZZ; Wang SK; Zhou ZX; Song DQ; Wang YM; Pan HN; Kong WJ; Jiang JD
    Metabolism; 2010 Feb; 59(2):285-92. PubMed ID: 19800084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Berberine improves glucose metabolism in diabetic rats by inhibition of hepatic gluconeogenesis.
    Xia X; Yan J; Shen Y; Tang K; Yin J; Zhang Y; Yang D; Liang H; Ye J; Weng J
    PLoS One; 2011 Feb; 6(2):e16556. PubMed ID: 21304897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and Verification of Potential Therapeutic Target Genes in Berberine-Treated Zucker Diabetic Fatty Rats through Bioinformatics Analysis.
    Wu YS; Chen YT; Bao YT; Li ZM; Zhou XJ; He JN; Dai SJ; Li CY
    PLoS One; 2016; 11(11):e0166378. PubMed ID: 27846294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the molecular mechanism of berberine for treating diabetic nephropathy based on network pharmacology.
    Yang L; Yuan S; Wang R; Guo X; Xie Y; Wei W; Tang L
    Int Immunopharmacol; 2024 Jan; 126():111237. PubMed ID: 37977063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoglycemic and insulin-sensitizing effects of berberine in high-fat diet- and streptozotocin-induced diabetic rats.
    Wang Y; Campbell T; Perry B; Beaurepaire C; Qin L
    Metabolism; 2011 Feb; 60(2):298-305. PubMed ID: 20304443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An integrated network pharmacology and transcriptomic method to explore the mechanism of the total Rhizoma Coptidis alkaloids in improving diabetic nephropathy.
    Xiao Y; Liu Y; Lai Z; Huang J; Li C; Zhang Y; Gong X; Deng J; Ye X; Li X
    J Ethnopharmacol; 2021 Apr; 270():113806. PubMed ID: 33444721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study on the mechanism of Gegen Qinlian Decoction for treating type II diabetes mellitus by integrating network pharmacology and pharmacological evaluation.
    Xu X; Niu L; Liu Y; Pang M; Lu W; Xia C; Zhu Y; Yang B; Wang Q
    J Ethnopharmacol; 2020 Nov; 262():113129. PubMed ID: 32730886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the protective effect of ShengMai-Yin and Ganmaidazao decoction combination against type 2 diabetes mellitus with nonalcoholic fatty liver disease by network pharmacology and validation in KKAy mice.
    Li S; Qian Y; Xie R; Li Y; Jia Z; Zhang Z; Huang R; Tuo L; Quan Y; Yu Z; Liu J; Xiang M
    J Ethnopharmacol; 2019 Oct; 242():112029. PubMed ID: 31216433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Berberine protects mice against type 2 diabetes by promoting PPARĪ³-FGF21-GLUT2-regulated insulin sensitivity and glucose/lipid homeostasis.
    Chen Y; Li Q; Zhao S; Sun L; Yin Z; Wang X; Li X; Iwakiri Y; Han J; Duan Y
    Biochem Pharmacol; 2023 Dec; 218():115928. PubMed ID: 37979703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of berberine on the renal tubular epithelial-to-mesenchymal transition by inhibition of the Notch/snail pathway in diabetic nephropathy model KKAy mice.
    Yang G; Zhao Z; Zhang X; Wu A; Huang Y; Miao Y; Yang M
    Drug Des Devel Ther; 2017; 11():1065-1079. PubMed ID: 28408805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Berberine promotes peri-implant osteogenesis in diabetic rats by ROS-mediated IRS-1 pathway.
    Shao J; Liu S; Zheng X; Chen J; Li L; Zhu Z
    Biofactors; 2021 Jan; 47(1):80-92. PubMed ID: 33233028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Berberine ameliorates glucocorticoid-induced hyperglycemia: an in vitro and in vivo study.
    Gupta M; Rumman M; Singh B; Mahdi AA; Pandey S
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Mar; 397(3):1647-1658. PubMed ID: 37704773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ameliorative effects of the Coptis inflorescence extract against lung injury in diabetic mice by regulating AMPK/NEU1 signaling.
    Wang L; Wang J; Ren G; Sun S; Nishikawa K; Yu J; Zhang C
    Phytomedicine; 2023 Sep; 118():154963. PubMed ID: 37516057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin receptor expression.
    Kong WJ; Zhang H; Song DQ; Xue R; Zhao W; Wei J; Wang YM; Shan N; Zhou ZX; Yang P; You XF; Li ZR; Si SY; Zhao LX; Pan HN; Jiang JD
    Metabolism; 2009 Jan; 58(1):109-19. PubMed ID: 19059538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect and mechanism of Jiao-tai-wan in the treatment of diabetes mellitus with depression based on network pharmacology and experimental analysis.
    Tang Y; Su H; Wang H; Lu F; Nie K; Wang Z; Huang W; Dong H
    Mol Med; 2021 Dec; 27(1):154. PubMed ID: 34875999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amorphous solid dispersion of Berberine mitigates apoptosis via iPLA
    Li J; Du H; Zhang M; Zhang Z; Teng F; Zhao Y; Zhang W; Yu Y; Feng L; Cui X; Zhang M; Lu T; Guan F; Chen L
    Int J Biol Sci; 2019; 15(7):1533-1545. PubMed ID: 31337982
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.